Clinical Trials Logo

Clinical Trial Details — Status: Suspended

Administrative data

NCT number NCT04896827
Other study ID # 2021-4227
Secondary ID
Status Suspended
Phase
First received
Last updated
Start date April 5, 2022
Est. completion date December 2024

Study information

Verified date November 2023
Source Université de Sherbrooke
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Chronic pain (CP) is disabling for people triggering important costs for society. A deficit of diffuse noxious inhibitory controls (DNIC) is one of the CP mechanisms. DNICs are evaluated in research setting using a CPM protocol (conditioned pain modulation). There is a lack of reference values on the effectiveness of DNICs. Wider research on DNIC will help to understand CP and to develop a clinical screening test evaluating DNICs. This study aims more specifically to determine whether it is possible to develop a facial recognition system to automate pain measurement and the effectiveness of pain control mechanisms.


Description:

This study aims: 1. To develop and validate a predictive tool (using deep learning and artificial intelligence) to estimate the efficacy of pain control mechanisms. 2. To estimate references values for facial expressions of pain control mechanisms in healthy and in chronic pain participants. The target population will be healthy volunteers and volunteers with chronic pain, male and female, stratified by age. The reference values (healthy volunteers) will be established via a non-parametric method for a standard conditioned pain modulation (CPM) protocol in which two "stimuli tests" of the same intensity and nature (heat) will be applied before and after the application of another "conditioning stimulus" (cold water bath). The perceived pain difference between the 1st and 2nd stimuli tests will reflect the intensity of the DNICs. Participants' facial expressions will be captured simultaneously by three cameras during the CPM testing. These results will be compared to those from volunteers suffering with chronic pain. The clinical decision rule will result from clinical and paraclinical elements correlating with the amplitude of the efficacy of CPM (serum noradrenaline, intensity of pain, heart rate and blood pressure measurements, psychometric questionnaires assessing anxiety, depressive feelings and pain catastrophizing). Logistic regression analysis will determine the best predictors of a CPM deficit.


Recruitment information / eligibility

Status Suspended
Enrollment 244
Est. completion date December 2024
Est. primary completion date August 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 79 Years
Eligibility Healthy participants Inclusion Criteria: - 18-79 years old - No chronic pain - Able to provide consent Exclusion Criteria: - Cardiovascular disease (arrhythmia, cerebrovascular accident, infarction...) - Raynaud syndrome - Severe psychiatric disease (dementia, schizophrenia, psychosis, major depression) - Injuries or loss sensitivity to their forearms or hands - Pregnant women or in post-partum period (<1 year) Participants with chronic pain Inclusion Criteria: - 18-79 years old - Chronic pain (chronic pain is defined by any regular pain for more than 6 months) - Able to provide consent Exclusion Criteria: - Cardiovascular disease (arrhythmia, cerebrovascular accident, infarction...) - Raynaud syndrome - Severe psychiatric disease (dementia, schizophrenia, psychosis, major depression) - Injuries or loss sensitivity to their forearms or hands - Pregnant women or in post-partum period (<1 year) - Chronic pain caused by cancer or migraine

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Conditioned pain modulation test
Conditioned pain modulation (CPM) protocol consist of evaluating pain during a heat test, before and after one conditioning stimulus (cold water bath); 3 cameras will be capturing participants' facial expressions during the tests.

Locations

Country Name City State
Canada Université de Sherbrooke Sherbrooke Quebec

Sponsors (3)

Lead Sponsor Collaborator
Université de Sherbrooke Centre for Research of CHUS (CRCHUS), Lucine

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Conditioned pain modulation (CPM) profiles Sensitivity and specificity of the classification algorithm according to different profiles (normal vs altered) of conditioned pain modulation, as defined by the change of pain perception before and after the cold water bath measured by computerized visual analog scale (CoVAS) ranging from 0 [no pain] to 100 [most intense pain that could be tolerated] in healthy and in chronic pain volunteers together. Once, at baseline, at recruitment (comparison between 1st and 2nd test, after the conditioning stimuli)
Primary Temporal summation profiles Sensitivity and specificity of the classification algorithm according to different profiles (normal vs altered) of temporal summation, as defined by the change of pain perception during the first stimuli test measured by computerized visual analog scale (CoVAS) ranging from 0 [no pain] to 100 [most intense pain that could be tolerated] in healthy and in chronic pain volunteers together. Once, at baseline, at recruitment (during the first stimuli test)
Secondary Conditioned pain modulation (CPM) profiles of healthy volunteers Conditioned pain modulation, as defined by the change of pain perception before and after the cold water bath measured by computerized visual analog scale (CoVAS) ranging from 0 [no pain] to 100 [most intense pain that could be tolerated] only in healthy volunteers. Once, at baseline, at recruitment (comparison between 1st and 2nd test, after the conditioning stimuli
Secondary Temporal summation profiles of healthy volunteers Temporal summation, as defined by the change of pain perception during the first stimuli test measured by computerized visual analog scale (CoVAS) ranging from 0 [no pain] to 100 [most intense pain that could be tolerated] only in healthy volunteers. Once, at baseline, at recruitment (during the first stimuli test)
Secondary Conditioned pain modulation (CPM) profiles of volunteers with chronic pain Conditioned pain modulation, as defined by the change of pain perception before and after the cold water bath measured by computerized visual analog scale (CoVAS) ranging from 0 [no pain] to 100 [most intense pain that could be tolerated] only in volunteers with chronic pain. Once, at baseline, at recruitment (comparison between 1st and 2nd test, after the conditioning stimuli)
Secondary Temporal summation profiles of volunteers with chronic pain Temporal summation, as defined by the change of pain perception during the first stimuli test measured by computerized visual analog scale (CoVAS) ranging from 0 [no pain] to 100 [most intense pain that could be tolerated] only in volunteers with chronic pain. Once, at baseline, at recruitment (during the first stimuli test)
Secondary Demographic factors Association of demographic factors (age, gender) with different response profiles of CPM and temporal summation established by the algorithm. Once, at baseline, at recruitment
Secondary Psychologic factors Association of psychologic factors (anxiety measured with HADS questionnaire) with different response profiles of CPM and temporal summation established by the algorithm. Once, at baseline, at recruitment
Secondary Physiologic factors Association of physiologic factors (continuous blood pressure, heart rate, electrodermal activity) with different response profiles of CPM and temporal summation established by the algorithm. Once, at baseline, at recruitment
Secondary Facial expressions and postures Association of facial expressions and postures with different response profiles of CPM and temporal summation established by the algorithm. Once, at baseline, at recruitment
See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Recruiting NCT05914311 - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration N/A
Recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Enrolling by invitation NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT06060028 - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain N/A
Recruiting NCT06204627 - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Not yet recruiting NCT05812703 - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain